Weekly News
 

January 21 | 2026

NASPGHAN Meets with FDA; Submits Comments on Biosimilarity Guidance


On January 15 physicians representing NASPGHAN, the American Academy of Pediatrics, the American Gastroenterological Association, Improve Care Now and the Crohn’s and Colitis Foundation met with FDA officials to discuss improving pathways for securing pediatric indications for IBD treatments. The meeting was a follow-up to comments sent by the organizations to the Food and Drug Administration (FDA) in 2024 in response to draft industry guidance for developing drugs for treatment of pediatric IBD. The meeting covered the use of extrapolation from adult studies, challenges with enrolling children and adolescents in clinical trials, and insurance barriers that impede access to biologic therapies that lack pediatric indications. NASPGHAN and the other participating societies are currently assessing next steps with the goal of continued engagement with the FDA.


In related news, this week NASPGHAN submitted a letter to the FDA in response to draft industry guidance on assessing the need for comparative effectiveness studies for demonstrating biosimilarity to a reference product. 
READ MORE

WEBINAR

FEBRUARY 25, 2026

8PM ET


As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.


Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. 


Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.
REGISTER


Watch your email and this newsletter space for details about a March 18 webinar, MASLD: What's That Again?, and as we continue to schedule the remainder of our exciting 2026 offerings!


2026 NASPGHAN ANNUAL MEETING



We're so excited to announce our 2026 Annual Meeting for October 21-24 in beautiful San Diego, California. Join your colleagues from across North America for cutting-edge science, practical education and meaningful collaboration in one of the country’s most vibrant coastal cities. Block off your calendars today, and look for more details, including registration, abstract submissions and program highlights, to be shared in the months ahead. We look forward to seeing you in San Diego in 2026!

NASPGHAN Committees are invited to submit relevant and timely topics for practice guideline consideration by Sunday, February 1st. NASPGHAN practice guideline proposals have moved to a biannual basis (February 1 and September 1). Should a Special Interest Group (SIG) under your purview want to submit a topic for consideration, they must first request approval from their respective Committee Chair. Before starting your proposal, please be sure to review the newly revised NASPGHAN Societal Manuscript Manual of Operations (MOO). Familiarity with the MOO will expedite review of your proposal.

2027 Webinar Submissions



We're excited to announce another year of accepting webinar submissions from individuals, SIGs and committees! All proposals will be reviewed by the Professional Education Committee and if approved, will be scheduled for 2027.


The submission site will open on February 2 and close on February 27. Our fabulous and skilled group of volunteers will take the month of March to review the submissions, and notifications will be made the first week of April.


Be sure to complete the submission form with care, as second rounds will not be offered for this cycle. Any suggestions by reviewers for changes to the webinar proposal will need to be made for the 2028 cycle. If you have any questions, please contact Kathleen Regan!
 

NASPGHAN | 714 North Bethlehem Pike | Ambler, PA 19002 US

Unsubscribe | Update Profile | Constant Contact Data Notice

Constant Contact